• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CMXHF:US

62.5500 USD 1.7000 2.65%

As of 20:10:00 ET on 07/25/2014.

Snapshot for CSL Ltd (CMXHF)

Open: 62.5500 Day's Range: 62.5500 - 62.5500 Volume: 1,570
Previous Close: 64.2500 52wk Range: 59.0600 - 66.0000 1-Yr Rtn: -

Stock Chart for CMXHF

No chart data available.
  • CMXHF:US 62.5500
  • 1D
  • 1M
  • 1Y
64.2500
Interactive CMXHF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMXHF

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 22.5243
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2014) 2.7770
Est. PEG Ratio 1.7625
Market Cap (M USD) 29,763.50
Shares Outstanding (M) 475.84
30 Day Average Volume 98
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.69%
Cash Dividend (AUD) 0.5888
Dividend Ex-Date 03/05/2014
5 Year Dividend Growth 22.91%
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMXHF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMXHF

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanHan Willem KottermanVice Chairman
Paul PerreaultCEO/Managing DirectorGordon NaylorChief Financial Officer
More Company Profile & Key Executives for CMXHF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil